Balyasny Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Balyasny Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-476,866	Closed	-$11.4M	–	2636
2021 Q1	$11.4M	Buy	+476,866	New	+$8.86M	0.06%	444
2018 Q3	–	Sell	-11,740	Closed	-$75K	–	2182
2018 Q2	$75K	Buy	+11,740	New	+$77.6K	﹤0.01%	1723
2018 Q1	–	Sell	-14,540	Closed	-$61K	–	2459
2017 Q4	$61K	Buy	+14,540	New	+$87.5K	﹤0.01%	2003

Balyasny Asset Management's GNMK Position: Q2 2021 in Review

Balyasny Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 476,866 shares — an estimated $11.4M sold.

Balyasny Asset Management first reported a position in GNMK in Q4 2017 and held it in 3 quarters. The position peaked at $11.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Balyasny Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Balyasny Asset Management sold 476,866 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $11.4M.
Balyasny Asset Management first reported a position in GenMark Diagnostics, Inc in Q4 2017 and held it in 3 quarters.
Balyasny Asset Management's GenMark Diagnostics, Inc position peaked at $11.4M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.